Rilmenidine treatment in patients with mild to moderate arterial hypertension and metabolic syndrome

Rilmenidine treatment in patients with mild to moderate arterial hypertension and metabolic syndrome

Efficacy, tolerability and cardioprotective properties of rilmenidine were examined in patients with mild to moderate arterial hypertension (AH). The trial involved 51 hypertensive subjects, mean age 57,7+2,5 years. After wash-out period, rilmenidine was administered in the daily dose of 1-2 mg. At...

Deskribapen osoa

Xehetasun bibliografikoak
Egile Nagusiak: S. S. Yakushin, N. I. Ivankova, N. S. Sazonova, N. V. Vilesova, G. O. Ivanova
Formatua: Artikulua
Hizkuntza:Russian
Argitaratua: «FIRMA «SILICEA» LLC 2004-12-01
Saila:Российский кардиологический журнал
Gaiak:
arterial hypertension
metabolic syndrome
cardioprotective effects
rilmenidine
Sarrera elektronikoa:https://russjcardiol.elpub.ru/jour/article/view/2326

Internet

https://russjcardiol.elpub.ru/jour/article/view/2326

Antzeko izenburuak